Intercellular Adhesion Molecule 1 Promotes HIV-1 Attachment but Not Fusion to Target Cells

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kondo, Naoyuki ^a   Melikyan, Gregory B ^a,b  

^a Emory Children's Center   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ARTICLE; ASSAY; CD4+ T LYMPHOCYTE; CELL FUSION; COLD; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERNALIZATION; LYMPHOID CELL; PROTEIN PROTEIN INTERACTION; TEMPERATURE DEPENDENCE; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS PARTICLE;

BLOTTING, WESTERN; CELL ADHESION; CELL LINE; ENDOCYTOSIS; HIV-1; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84866103753     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044827     Document Type: Article

References (81)

1. Gallo SA, Finnegan CM, Viard M, Raviv Y, Dimitrov A, et al. (2003) The HIV Env-mediated fusion reaction. Biochim Biophys Acta 1614: 36-50.
2. Checkley MA, Luttge BG, Freed EO, (2011) HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol 410: 582-608.
3. Melikyan GB, (2011) Membrane fusion mediated by human immunodeficiency virus envelope glycoprotein. Curr Top Membr 68: 81-106.
4. Wyatt R, Sodroski J, (1998) The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280: 1884-1888.
5. Melikyan GB, (2008) Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology 5: 111.
6. Ashkenazi A, Shai Y, (2011) Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides. Eur Biophys J 40: 349-357.
7. Sato H, Orenstein J, Dimitrov D, Martin M, (1992) Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 186: 712-724.
8. Carr JM, Hocking H, Li P, Burrell CJ, (1999) Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology 265: 319-329.
9. Sattentau Q, (2008) Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6: 815-826.
10. Kimpton J, Emerman M, (1992) Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 66: 2232-2239.
11. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, et al. (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749-1754.
12. Bourinbaiar AS, (1994) The ratio of defective HIV-1 particles to replication-competent infectious virions. Acta Virol 38: 59-61.
13. Layne SP, Merges MJ, Dembo M, Spouge JL, Conley SR, et al. (1992) Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189: 695-714.
14. Marozsan AJ, Fraundorf E, Abraha A, Baird H, Moore D, et al. (2004) Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates. J Virol 78: 11130-11141.
15. Rusert P, Fischer M, Joos B, Leemann C, Kuster H, et al. (2004) Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology 326: 113-129.
16. Miyauchi K, Kozlov MM, Melikyan GB, (2009) Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation. PLoS Pathog 5: e1000585.
17. O'Doherty U, Swiggard WJ, Malim MH, (2000) Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74: 10074-10080.
18. Platt EJ, Kozak SL, Durnin JP, Hope TJ, Kabat D, (2010) Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions. J Virol 84: 3106-3110.
19. Miyauchi K, Marin M, Melikyan GB, (2011) Visualization of retrovirus uptake and delivery into acidic endosomes. Biochem J 434: 559-569.
20. Gelderblom H, Reupke H, Winkel T, Kunze R, Pauli G, (1987) MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses. Z Naturforsch C 42: 1328-1334.
21. Hoxie JA, Fitzharris TP, Youngbar PR, Matthews DM, Rackowski JL, et al. (1987) Nonrandom association of cellular antigens with HTLV-III virions. Hum Immunol 18: 39-52.
22. Arthur LO, Bess JW Jr., Sowder RC, 2nd, Benveniste RE, Mann DL, et al (1992) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258: 1935-1938.
23. Orentas RJ, Hildreth JE, (1993) Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res Hum Retroviruses 9: 1157-1165.
24. Capobianchi MR, Fais S, Castilletti C, Gentile M, Ameglio F, et al. (1994) A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J Infect Dis 169: 886-889.
25. Franke EK, Yuan HE, Luban J, (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372: 359-362.
26. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, et al. (1994) Functional association of cyclophilin A with HIV-1 virions. Nature 372: 363-365.
27. Tremblay MJ, Fortin JF, Cantin R, (1998) The acquisition of host-encoded proteins by nascent HIV-1. Immunol Today 19: 346-351.
28. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, et al. (2006) Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 80: 9039-9052.
29. Scholer A, Hugues S, Boissonnas A, Fetler L, Amigorena S, (2008) Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory. Immunity 28: 258-270.
30. Lawson C, Wolf S, (2009) ICAM-1 signaling in endothelial cells. Pharmacol Rep 61: 22-32.
31. Wang SC, Kanner SB, Ledbetter JA, Gupta S, Kumar G, et al. (1995) Evidence for LFA-1/ICAM-1 dependent stimulation of protein tyrosine phosphorylation in human B lymphoid cell lines during homotypic adhesion. J Leukoc Biol 57: 343-351.
32. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC, (1989) Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83: 2008-2017.
33. Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, et al. (1999) Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol 163: 5029-5038.
34. Henderson RB, Lim LH, Tessier PA, Gavins FN, Mathies M, et al. (2001) The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med 194: 219-226.
35. Springer TA, Dustin ML, Kishimoto TK, Marlin SD, (1987) The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 5: 223-252.
36. Cabanas C, Sanchez-Madrid F, (1999) CD11a (leukocyte integrin LFA-1 alpha subunit). J Biol Regul Homeost Agents 13: 126-129.
37. Hogg N, Smith A, McDowall A, Giles K, Stanley P, et al. (2004) How T cells use LFA-1 to attach and migrate. Immunol Lett 92: 51-54.
38. Saphire AC, Gallay PA, Bark SJ, (2006) Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J Proteome Res 5: 530-538.
39. Beausejour Y, Tremblay MJ, (2004) Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1. J Virol 78: 11916-11925.
40. Fortin JF, Cantin R, Lamontagne G, Tremblay M, (1997) Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol 71: 3588-3596.
41. Rizzuto CD, Sodroski JG, (1997) Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J Virol 71: 4847-4851.
42. Bounou S, Leclerc JE, Tremblay MJ, (2002) Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J Virol 76: 1004-1014.
43. Fortin JF, Cantin R, Tremblay MJ, (1998) T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol 72: 2105-2112.
44. Tardif MR, Tremblay MJ, (2003) Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material. J Virol 77: 12299-12309.
45. Paquette JS, Fortin JF, Blanchard L, Tremblay MJ, (1998) Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol 72: 9329-9336.
46. Fortin JF, Cantin R, Bergeron MG, Tremblay MJ, (2000) Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. Virology 268: 493-503.
47. Losier M, Fortin JF, Cantin R, Bergeron MG, Tremblay MJ, (2003) Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase. Clin Immunol 108: 111-118.
48. Shimaoka M, Takagi J, Springer TA, (2002) Conformational regulation of integrin structure and function. Annu Rev Biophys Biomol Struct 31: 485-516.
49. Laudanna C, (2005) Integrin activation under flow: a local affair. Nat Immunol 6: 429-430.
50. Bazil V, Stefanova I, Hilgert I, Kristofova H, Vanek S, et al. (1990) Monoclonal antibodies against human leucocyte antigens. IV. Antibodies against subunits of the LFA-1 (CD11a/CD18) leucocyte-adhesion glycoprotein. Folia Biol (Praha) 36: 41-50.
51. Marlin SD, Springer TA, (1987) Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51: 813-819.
52. Cavrois M, De Noronha C, Greene WC, (2002) A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol 20: 1151-1154.
53. Tardif MR, Tremblay MJ, (2005) Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes. J Immunol 175: 926-935.
54. Yi Y, Isaacs SN, Williams DA, Frank I, Schols D, et al. (1999) Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. J Virol 73: 7117-7125.
55. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB, (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137: 433-444.
56. de la Vega M, Marin M, Kondo N, Miyauchi K, Kim Y, et al. (2011) Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion. Retrovirology 8: 99.
57. Lin PF, Blair W, Wang T, Spicer T, Guo Q, et al. (2003) A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding. Proc Natl Acad Sci U S A 100: 11013-11018.
58. Si Z, Madani N, Cox JM, Chruma JJ, Klein JC, et al. (2004) Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins. Proc Natl Acad Sci U S A 101: 5036-5041.
59. Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M, (2007) Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor. Biochemistry 46: 4360-4369.
60. Daecke J, Fackler OT, Dittmar MT, Krausslich HG, (2005) Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol 79: 1581-1594.
61. Carter GC, Bernstone L, Baskaran D, James W, (2011) HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 409: 234-250.
62. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, et al. (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839-850.
63. Krummel MF, Davis MM, (2002) Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr Opin Immunol 14: 66-74.
64. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ, (2004) HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 199: 283-293.
65. Arias RA, Munoz LD, Munoz-Fernandez MA, (2003) Transmission of HIV-1 infection between trophoblast placental cells and T-cells take place via an LFA-1-mediated cell to cell contact. Virology 307: 266-277.
66. Fromentin R, Tardif MR, Tremblay MJ, (2010) Human hepatoma cells transmit surface bound HIV-1 to CD4+ T cells through an ICAM-1/LFA-1-dependent mechanism. Virology 398: 168-175.
67. Hildreth JE, Orentas RJ, (1989) Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244: 1075-1078.
68. Tardif MR, Tremblay MJ, (2005) LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1. J Virol 79: 13714-13724.
69. Tardif MR, Gilbert C, Thibault S, Fortin JF, Tremblay MJ, (2009) LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20. Antimicrob Agents Chemother 53: 4656-4666.
70. Hioe CE, Tuen M, Vasiliver-Shamis G, Alvarez Y, Prins KC, et al. (2011) HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). PLoS One 6: e23202.
71. Jolly C, Mitar I, Sattentau QJ, (2007) Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells. J Virol 81: 13916-13921.
72. Sanders RW, de Jong EC, Baldwin CE, Schuitemaker JH, Kapsenberg ML, et al. (2002) Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J Virol 76: 7812-7821.
73. Puigdomenech I, Massanella M, Izquierdo-Useros N, Ruiz-Hernandez R, Curriu M, et al. (2008) HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4. Retrovirology 5: 32.
74. Hubner W, McNerney GP, Chen P, Dale BM, Gordon RE, et al. (2009) Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 323: 1743-1747.
75. Bosch B, Grigorov B, Senserrich J, Clotet B, Darlix JL, et al. (2008) A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission. Antiviral Res 80: 185-193.
76. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, et al. (2002) Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 46: 1896-1905.
77. Lusso P, Cocchi F, Balotta C, Markham PD, Louie A, et al. (1995) Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J Virol 69: 3712-3720.
78. Binley JM, Cayanan CS, Wiley C, Schulke N, Olson WC, et al. (2003) Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J Virol 77: 5678-5684.
79. Malim MH, Hauber J, Fenrick R, Cullen BR, (1988) Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335: 181-183.
80. Tobiume M, Lineberger JE, Lundquist CA, Miller MD, Aiken C, (2003) Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J Virol 77: 10645-10650.
81. Hammonds J, Chen X, Zhang X, Lee F, Spearman P, (2007) Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines. Vaccine 25: 8036-8048.